Recent 13F filings as of September 2025 show that 55 institutional investors hold a position in Benitec Biopharma Inc. (NASDAQ:BNTC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 9,876,506 | 0 | 0.00% | $138,567,379.00 |
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 2,911,688 | 8,894 | 0.31% | $40,705,398.00 |
| FRANKLIN RESOURCES INC | 30 Sep, 2025 | 2,589,633 | -111,810 | -4.14% | $36,332,551.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 30 Sep, 2025 | 1,972,524 | 0 | 0.00% | $27,674,512.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 992,114 | 22,948 | 2.37% | $13,919,360.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 945,515 | 226,825 | 31.56% | $13,265,576.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 838,095 | 0 | 0.00% | $11,758,473.00 |
| INFINITUM ASSET MANAGEMENT, LLC | 30 Sep, 2025 | 500,000 | 0 | 0.00% | $7,015,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 438,505 | 23,294 | 5.61% | $6,153,972.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 276,267 | 23,033 | 9.10% | $3,876,026.00 |
| Schonfeld Strategic Advisors LLC | 30 Sep, 2025 | 260,419 | 2 | 0.00% | $3,653,678.00 |
| STATE STREET CORP | 30 Sep, 2025 | 218,398 | 57,325 | 35.59% | $3,064,124.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 194,363 | 173,369 | 825.80% | $2,726,913.00 |
| AWM Investment Company, Inc. | 30 Sep, 2025 | 182,977 | 45,000 | 32.61% | $2,567,167.00 |
| AMERIPRISE FINANCIAL INC | 30 Sep, 2025 | 154,414 | 44,489 | 40.47% | $2,166,428.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 130,615 | 4,293 | 3.40% | $1,832,528.00 |
| UBS Group AG | 30 Sep, 2025 | 99,941 | 82,057 | 458.83% | $1,402,172.00 |
| Simplify Asset Management Inc. | 30 Sep, 2025 | 78,725 | 9,552 | 13.81% | $1,104,512.00 |
| ExodusPoint Capital Management, LP | 30 Sep, 2025 | 77,912 | 1,533 | 2.01% | $1,093,105.00 |
| MYDA Advisors LLC | 30 Sep, 2025 | 70,000 | 7,884 | 12.69% | $982,100.00 |